Tirzepatide, nerve stimulation, and oral AD109 are reshaping OSA care as phenotyping replaces the one-size-fits-all CPAP default.
Ashesha Mechineni, MD
Advertisement
Ashesha Mechineni, MD, is a clinical assistant professor at University of Illinois Chicago.
Articles by Ashesha Mechineni, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
The Risk of Waiting: The Case for Lower LDL-C – Earlier in the Atherosclerotic Disease Continuum
2
Sleep Hygiene Counseling for Cardiovascular Risk Reduction in Primary Care
3
FDA Issues CRL to Cytisinicline for Smoking Cessation
4
Social Determinants May Improve Disease Risk Prediction Beyond Genetics Alone
5